Resolian Bioanalytics is a leading global research laboratory providing services for the pharmaceutical, biotechnology, and medical device industries.
Sanofi Australia is part of a global healthcare organisation that employs over 100,000 people across 170 countries. Our purpose is to bring hope, relief and cures to patients with the medicines and vaccines that we make. Established in Australia in 1980, our heritage spans 100 years, pioneering medicine across broad therapeutic areas including diabetes, cardiovascular disease, influenza, oncology, immunology, rare diseases and rare blood disorders. Today in Australia we are a leading supplier of diabetes medicines and vaccines. We strive to provide quality vaccination coverage from infectious diseases to all Australians. 95% of young Australian’s will have had a Sanofi vaccine by age five, and one in four Australians has had one of our flu vaccines. Due to our global manufacturing network and dedicated local team of over 700 people, we reliably supply quality innovative vaccines, medicines and healthcare solutions, throughout the country, enabling those in rural and remote locations to access our treatments. Our breakthrough science, technology and unique collaborations allow us to accelerate access to scientific innovation and benefit the lives of patients who depend on us. From the many with rare conditions, the millions with chronic disease to those seeking protection from infectious disease. In collaboration with clinicians, our clinical trials are an important phase of our research, and annually supports access for over 500 Australians to many scientific innovations including those for atopic dermatitis, multiple sclerosis and haemophilia. Inclusion and diversity are at the heart of our culture, allowing our people to feel heard, valued and respected. We embrace news ways of thinking, which is integral to innovation, and allows us to better understand, connect and meet the health needs of people in Australia.
Servatus BioPharmaceuticals Limited are a biopharmaceutical research and production company, based on the Sunshine Coast, Queensland. Established in 2012, we research, develop and produce high-quality, innovative, medical grade biopharmaceuticals based on the latest scientific research. Servatus has two drug research platforms: Engineered proteins for the treatment of autoimmune diseases, and microbial biotherapeutics for the treatment of inflammatory conditions and bacterial infections.
We are a Australian contract development and manufacturing organisation (CDMO) specialising in the production of nucleic acid products (mRNA) that support life-enabling work. We support our customers by providing scalable manufacturing capacity and help them accelerate innovation in bringing their products from benchtop to bedside or field. Developing and deploying our state-of-the-art bioprocessing and chemical process technologies, using proprietary manufacturing approaches, employing a highly-skilled Australian workforce.
Springfield City Group develops commercial, educational, healthcare, and residential real estate projects, with a vision of making Greater Springfield a sustainable regional city and services hub by 2030. BioPark Australia is to create a place where multiple biologic industries (Therapeutics, Vaccines, Med Tech, Diagnostics will co-locate and grow. Central to the BioPark will be its provision of the complete suite of necessary components and reagents for these industries. Future-proofing is built-in with staged expansion sites available to users.
Recognised for the experience and calibre of its people and high client service standards, Spruson & Ferguson is one of the largest and most trusted intellectual property (IP) service providers in the Asia Pacific region. Our life sciences team in Queensland provide strategic filing advice and services to a wide range of innovators, researchers, universities and businesses. Operating from 10 offices as a regional IP hub, clients can file in over 25 jurisdictions with a single instruction. Offices: Australia, Singapore, China (Beijing & Hong Kong), Indonesia, Malaysia, Philippines, Thailand. Spruson & Ferguson is a member of IPH Limited, an international IP services group comprising a network of member firms working throughout ten IP jurisdictions.
Thomson Geer is a large Australian corporate law firm, delivering services to a wide range of industry sectors and practice areas. Thomson Geer has offices in Sydney, Melbourne, Brisbane and Adelaide. By size, they are one of the 10 largest law firms in Australia.
Trade and Investment Queensland is the Queensland Government’s dedicated global business agency, helping Queensland exporters take their products to world markets and promoting Queensland as the perfect place for investment.
Initially qualified in the Medical Laboratory Sciences, Trevor has been involved in the Healthcare/Biotechnology sector for >30 years in various roles of laboratory, sales, marketing, operational and general management of both multinationals, Australian and self-owned companies.
The Translational Research Institute (TRI) is an Australian initiative focused on advancing medical research from the laboratory to the community. Combining clinical and translational research, TRI aims to enhance detection, diagnosis, and treatment methods for various health conditions, ultimately improving patient outcomes. Their work spans across different areas, including cancer, autoimmune diseases, and more, with a focus on developing innovative treatments and diagnostics that can be translated into better healthcare practices.
UniQuest is Australia’s leading commercialisation entity, specialising in commercialising the intellectual property of The University of Queensland, a global top 50 university. Uniquest benchmarks in the top tier of technology transfer worldwide.
USC Clinical Trials, in collaboration with healthcare professionals in the Sunshine Coast and Moreton Bay, offers expert services for all phases of drug and device clinical trials. They have a wide range of therapeutic areas in their expanding portfolio. The team comprises experienced Principal and Sub-Investigators who are matched to each study based on their expertise. With over 40 completed and ongoing studies across phases I to IV, USC Clinical Trials has the necessary experience to support your research.
A young, fresh university driven by an unwavering belief that community and culture is just as important as a world-class education, delivered by world-class educators. We may not be the biggest university, but we’re growing fast, and doing big things. Like ground-breaking research, championing sustainability, producing gold-winning athletes and award-winning alumni. Our first campus, on the Sun
The $70 million UQ Centre for Clinical Research (CCR) at the Royal Brisbane and Women's Hospital (RBWH) is focused on improving people's lives through patient-orientated research. Offer state-of-the-art facilities and bring together leading health professionals, clinicians and scientists from around the globe.
The University of Queensland is one of Australia’s leading research and teaching institutions. We strive for excellence through the creation, preservation, transfer and application of knowledge. For more than a century, we have educated and worked with outstanding people to deliver knowledge leadership for a better world.UQ is consistently ranked among the world's top 50 universities. In the 2022 Aggregate Ranking of Top Universities, UQ ranked 2nd in Australia and 42nd in the world.
Urmi Quality Management Consulting (UQMC) help life science organizations establish compliant and phase-appropriate quality systems that adapt to the changing needs of the business. Combining knowledge and experience from both the Pharmaceutical and ISO 9001 Quality Management System, UQMC consultants assist life science start-ups, CDMOs, commercial manufacturers and supporting industries in adopting quality system elements that enable leaner, compliant and robust operations.
VFV is a fluid technology company providing fluid handling solutions in life sciences and design.
Vaxxas is commercialising novel technology that dramatically enhances the performance of existing next-generational vaccines. Their delivery platform enables robust immune system activation by targeting vaccine components to the abundant immunological cells immediately below the skin’s surface. Vaxxas’ proprietary Nanopatch™ technology aims to provide an optimised, differentiated needle-free vaccine delivery solution that safely and cost effectively amplifies vaccine efficacy.
Led by Director and Founder Dr. Patrick Silvey a specialist in Innovation Project design and scoping, VenturePro supports companies, government agencies, not-for-profits, and research organisations to become investment-ready. Dr. Silvey channels the talent and passion of VenturePro’s clients to turn discoveries and ideas into market-ready solutions or evidence-based policies for a better world. Over 18 years VenturePro has helped secure over $2.05 billion in funding for both short and long-term innovation projects and high-growth ventures.
WearOptimo is an Australian Healthtech company at the forefront of wearables and precision medicine. Our unique and patented Microwearable platform is designed to access and interpret key health signals continuously, remotely, and in real-time, while being unobtrusive and pain-free to the user.
West is a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable medicines. We are a trusted partner to the world’s top pharmaceutical and biotechnology companies—working by their side to improve patient health.
Women in Technology (WiT) is one of Australia’s biggest communities that support women in across all fields of science and technology. As a not-for-profit organisation, we exist solely to create opportunities for our members and provide a dynamic platform to empower women from all disciplines to unlock their career potential. For more than two decades we have helped women find the inspiration and support they need to achieve their aspirations and, in doing so, we are helping our community take full advantage of the outstanding talent, energy and capacity they bring to our emerging digital economy.
Patheon Biologics, a division of Thermo Fisher Scientific, offers comprehensive pharmaceutical services to support the entire biotechnology and pharmaceutical life cycle. Thermo Fisher's pharma services solutions aid customers in accelerating innovation and enhancing productivity in drug development and commercialization. As a strategic contract development and manufacturing organization (CDMO) and clinical services partner, they serve the pharmaceutical, biotech, and life sciences industries. At their mammalian-based cGMP facility in Brisbane, Australia, Patheon supports clients in large-scale GMP manufacturing of biopharmaceuticals.
%20(1).png)
%20(003).jpg){kind=logo}
.png)
